Cancer nanotechnology is a branch of ... and the competition between fluorescence emission and reactive oxygen species generation. Here, the authors report an anionic pentamethine-based ...
Hosted on MSN27d
Innovent Biologics Gains Approval for New Cancer Druga next-generation treatment for ROS1-positive non-small cell lung cancer. This marks the 13th addition to Innovent’s portfolio, highlighting the company’s commitment to innovative cancer ...
Telomir announced results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of ...
with priority review for the investigational next-generation ROS1 tyrosine kinase inhibitor (TKI) taletrectinib in the treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC), according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback